ABI Research: for visionaries

Shares of protein discovery platform Absci pop in market debut

TechCrunch | July 22, 2021, 3:27 p.m.


Absci Corp., a Vancouver company behind a multi-faceted drug development platform, went public on Thursday. It’s another sign of snowballing interest in new approaches to drug development – a traditionally risky business.  Absci focuses on speeding drug development in the preclinical stages. The company has developed and acquired a handful of tools that can predict […]

Read Full Article